The tweet was deleted by the author.
But we saved everything 🙂.
CVRx has announced a partnership with Dr. Gilbert Postler, Dr. Michol Cooper, and the team at Florida Medical Clinic Orlando Health for their first Barostim implant.
This collaboration allows patients in the region to access a novel device therapy specifically designed to improve symptoms of heart failure. The Barostim implant is considered an innovative solution in device-based heart failure treatment, expanding therapeutic options for clinicians and patients. The partnership underscores CVRx's ongoing commitment to advancing cardiovascular care through strategic medical collaborations.
View post on X Loading...
CVRx recently completed its sixth Barostim implant at The Mount Sinai Hospital, marking steady progress in its device therapy rollout. Executive Philip Adamson previously outlined the company's approach to heart failure treatment in a medical podcast appearance. The company continues to expand partnerships with medical centers nationwide.